Access for Life: Pioneering Hemodialysis Innovation

We are a venture-backed medical device start-up at the forefront of hemodialysis innovation. Led by its inventors and management team, the company collaborates with renowned medical consultants and development engineers to bring its patented technology to market. Currently undergoing in-vivo trials, Access for Life's devices hold the potential to revolutionize vascular access for patients with chronic kidney disease.

 

Access for Life secured an investment from Pharmes Innovations Limited, a leading boutique medical device accelerator. This strategic partnership strengthens our financial position and bolsters our leadership team. David Grey, Senior Partner at Pharmes Innovations, brings his extensive experience to the our Board of Directors, further accelerating our mission to revolutionize hemodialysis care.

 

Access for Life: Founded by Medical Expertise, Driven by Business Acumen

Access for Life was born from the vision of Dr. Roger Mason, a highly respected Yale-trained vascular and general surgeon. Dr. Mason's clinical expertise serves as the foundation for our innovative technology. Our leadership team leverages this medical knowledge with a powerful combination of talent:

• Seasoned Vascular Surgeons and Nephrologists: Provide unparalleled clinical insight and guidance.

• Experienced Business Professionals: Steer strategic direction and ensure efficient operations.